Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona. Show More...
-
Website http://acceleratediagnostics.com
-
Sector Healthcare
-
Industry Diagnostics & Research
-
Last Quote 0.04 USD
-
Last Updated 15-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-07 2011-07 2012-07 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 0.06 -0.04 -0.43 -0.41 -0.71 -1.01 -1.29 -1.18 -1.62 -1.55 -1.54 Dividends USD Payout Ratio % * Shares Mil 10.0 11.0 12.0 38.0 44.0 45.0 51.0 54.0 54.0 55.0 55.0 Book Value Per Share * USD 1.08 1.62 0.79 1.77 2.33 1.43 0.19 -0.42 Free Cash Flow Per Share * USD -0.05 -0.42 -0.74 -1.08 -1.08 -1.25 -1.21 Return on Assets % 11.16 -6.04 -45.24 -53.86 -54.64 -43.51 -59.75 -61.46 -56.84 -52.74 -57.43 Financial Leverage (Average) 1.28 1.3 1.16 1.05 1.06 1.05 1.06 1.06 3.23 Return on Equity % 14.58 -7.79 -54.05 -57.04 -57.55 -45.72 -62.96 -65.16 -100.33 -337.25 -837.84 Return on Invested Capital % 14.49 -8.0 -54.23 -57.16 -57.48 -45.74 -63.23 -65.72 -39.89 -47.85 -51.28 Interest Coverage -7.71 -4.92 -4.79 Current Ratio 9.93 20.52 10.81 37.07 24.11 25.28 19.44 17.75 22.88 14.93 16.03 Quick Ratio 9.24 19.79 10.79 36.95 23.99 24.97 19.28 16.37 21.68 13.68 14.29 Debt/Equity 2.09